Bjerkholt Eric
- SEC CIK
- 0001197350
In the past year, 8 open-market sale filings worth $3.62M and no purchases.
Current role at each company
- MIRM Mirum Pharmaceuticals, Inc.CHIEF FINANCIAL OFFICERas of Sep 15, 2026
- CERS Cerus CorpDirectoras of Jun 11, 2026
- MGX Metagenomi Therapeutics, Inc.Directoras of Jun 11, 2026
- SRZN Surrozen, Inc.Directoras of May 14, 2026
- CALC CalciMedica, Inc.Directoras of Aug 28, 2024
Show 1 more company
- KDNY Chinook Therapeutics, Inc.Chief Financial Officeras of Aug 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.62M
- 8 filings
- Net
- −$3.62M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Bjerkholt Eric as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MIRM Mirum Pharmaceuticals, Inc.
CHIEF FINANCIAL OFFICER12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)4:10 PM ET | Sep 14 | 1 day | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −9.94K | $98.37 | −$978.1K | −18.2%44.7K after | |
| Aug 12, 2026 (view filing)5:14 PM ET | Aug 11 | 1 day | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −6.00K | $99.90 | −$599.5K | −14.2%36.4K after | 10b5-1 |
| Jul 8, 2026 (view filing)5:07 PM ET | Jul 6 | 2 days | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −5.00K | $122.25 | −$611.3K | −10.6%42.2K after | 4 lots10b5-1 |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −5.00K | $93.82 | −$469.1K | −10.0%44.8K after | 3 lots10b5-1 |
| Mar 17, 2026 (view filing) | Mar 16 | 1 day | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −7.29K | $91.98 | −$670.3K | −12.8%49.8K after | |
| Jan 27, 2026 (view filing) | Jan 26 | 1 day | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −1.05K | $96.19 | −$101.3K | −2.4%43.7K after | |
| Jan 23, 2026 (view filing) | Jan 22 | 1 day | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −1.42K | $93.33 | −$132.6K | −3.3%42.1K after | |
| Sep 12, 2025 (view filing) | Sep 12 | Same day | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −9.58K | $76.01 | −$728.0K | −19.3%39.9K after | |
| Aug 12, 2025 (view filing) | Aug 11 | 1 day | Bjerkholt EricCHIEF FINANCIAL OFFICER | SSale | −8.00K | – | – | −22.1%28.2K after | |
| Mar 27, 2024 (view filing) | Mar 27 | Same day | Bjerkholt EricCHIEF FINANCIAL OFFICER | PPurchase | +2.00K | $24.80 | +$49.6K | +16.7%14.0K after |
CERS Cerus Corp
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 (view filing) | Jun 9 | 2 days | Bjerkholt EricDirector | SSale | −20.5K | $2.60 | −$53.2K | −7.2%261.7K after | |
| Dec 16, 2024 (view filing) | Dec 12 | 4 days | Bjerkholt EricDirector | SSale | −20.0K | $1.79 | −$35.8K | −11.0%162.1K after | |
| Dec 13, 2023 (view filing) | Dec 13 | Same day | Bjerkholt EricDirector | PPurchase | +10.0K | $1.62 | +$16.2K | +7.6%142.1K after | |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Bjerkholt EricDirector | PPurchase | +10.0K | $1.72 | +$17.2K | +8.2%132.1K after | |
| May 23, 2023 (view filing) | May 23 | Same day | Bjerkholt EricDirector | PPurchase | +5.00K | $2.00 | +$10.0K | +6.5%82.1K after |
CALC CalciMedica, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 (view filing) | May 30-31 | 2 days | Bjerkholt EricDirector | PPurchase | +255 | $4.14 | +$1.06K | +7.4%3.68K after | 3 lots |
| May 24, 2023 (view filing) | May 23 | 1 day | Bjerkholt EricDirector | PPurchase | +500 | $3.27 | +$1.64K | +17.1%3.43K after | |
| May 22, 2023 (view filing) | May 18-19 | 4 days | Bjerkholt EricDirector | PPurchase | +200 | $2.65 | +$530 | +7.3%2.93K after | 2 lots |
| May 18, 2023 (view filing) | May 16-18 | 2 days | Bjerkholt EricDirector | PPurchase | +1.30K | $2.70 | +$3.50K | +91.0%2.73K after | 3 lots |
KDNY Chinook Therapeutics, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 (view filing) | Feb 10 | 5 daysLate | Bjerkholt EricChief Financial Officer | SSale | −857 | $23.75 | −$20.4K | −2.2%38.9K after | |
| Feb 2, 2023 (view filing) | Jan 31 | 2 days | Bjerkholt EricChief Financial Officer | SSale | −2.89K | $24.68 | −$71.3K | −7.2%37.3K after | |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Bjerkholt EricChief Financial Officer | SSale | −5.77K | $22.29 | −$128.6K | −14.9%32.8K after | |
| Feb 14, 2022 (view filing) | Feb 11 | 3 days | Bjerkholt EricChief Financial Officer | SSale | −895 | $12.74 | −$11.4K | −3.9%22.2K after |